Novartis Investigative Site

Iruma-gun, Saitama 3500495

1 studies enrolling now · 3 studies all time

What they study most

Atypical Hemolytic Uremic Syndrome, Diffuse Cutaneous Systemic Sclerosis, Primary Immune Thrombocytopenia (ITP)

Studies at this site

• A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis — Recruiting now
• Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy — Completed
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling